Banner

Small Molecule Active Pharmaceutical Ingredient Global Market Report 2023– By Type (Synthetic, Chemical, Biological), By Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology), By Manufacturing Method (In-House, Contract), By Application (Clinical, Commercial)– Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 200 | Published : January 2023 | SKU CODE : | Delivery Time: 2-3 business days | Format :


A small-molecule active pharmaceutical ingredient (API) is any substance or mixture of organic substances or compounds with a low molecular weight intended to be used as the active ingredient in the manufacture of a drug or medicinal product. A small molecule active pharmaceutical ingredient (API) is used as raw materials in the manufacturing of pharmaceutical drugs.

The main types of small molecule active pharmaceutical ingredient markets are synthetic, chemical, and biological. Synthetics are engaged in the manufacturing of pharmaceutical drugs. Synthetic chemical APIs, also known as small molecules, constitute a large part of the pharmaceutical market, with many small molecule drugs commercially available in the market. The various therapeutic types are autoimmune diseases, oncology, metabolic diseases, ophthalmology, cardiovascular diseases, infectious diseases, neurology, respiratory disorders, dermatology, and urology. The manufacturing methods are in-house and contract. The applications are clinical and commercial.

The small molecule active pharmaceutical ingredient market research report is one of a series of new reports from The Business Research Company that provides small molecule active pharmaceutical ingredient market statistics, including small molecule active pharmaceutical ingredient industry global market size, regional shares, competitors with a small molecule active pharmaceutical ingredient market share, detailed small molecule active pharmaceutical ingredient market segments, market trends and opportunities, and any further data you may need to thrive in the small molecule active pharmaceutical ingredient industry. This small molecule active pharmaceutical ingredient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global small molecule active pharmaceutical ingredient market size is expected to grow from $167.59 billion in 2022 to $180.76 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The small molecule active pharmaceutical ingredient market size is expected to grow to $241.11 billion in 2027 at a CAGR of 7.5%.

The increasing prevalence of diseases is a major driver propelling the small molecule active pharmaceutical ingredient (API) market. A disease is a particular abnormal condition, a disorder of a structure or function, that affects the body of the patient. Active pharmaceutical ingredients (APIs) are the active components in a pharmaceutical drug that produce the required effect on the body to treat various conditions. For instance, according to the data from the World Health Organization (WHO), a body of the United Nations responsible for international public health, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. And, in 2020, the bulk of the approximately 422 million individuals with diabetes globally will reside in low- and middle-income nations, and diabetes is directly responsible for 1.5 million fatalities annually. Cardiovascular diseases have resulted in the deaths of 17.9 million people worldwide. Therefore, the increasing prevalence of diseases will continue to be the key driver in the small molecule API market.

Strategic partnerships and collaborations have emerged as the key trend gaining popularity in the small molecule active pharmaceutical ingredient market. Key players operating in the small molecule active pharmaceutical ingredient sector are focused on partnerships and collaborations to reinforce their positions. For instance, in May 2022, NovAliX, a France-based drug discovery company; Alysophil, a France-based company creating new industrial chemistry based on continuous flow chemistry; De Dietrich Process Systems, a France-based provider of solutions for the fine chemical and pharmaceutical industries; and Bruker, a US-based manufacturer of scientific instruments for molecular and materials research, collaborated. Through this partnership, the companies aim to jointly develop a new approach to active pharmaceutical ingredient (API) production and offer complete, standalone, and location-independent API manufacturing solutions to pharmaceutical companies or contract manufacturing organisations (CMOs).

In March 2021, Piramal Pharma, an India-based pharmaceutical company, acquired Hemmo Pharmaceuticals for a deal amount of $7.75 billion (775 crores). Through this acquisition, Piramal Pharma aims to gain access to the growing peptide active pharmaceutical ingredients (API) market. Hemmo pharmaceutical is an India-based manufacturer that produces peptide products and custom peptide synthesis.

Major players in the market are Albemarle Corporation, Aurobindo Pharma Limited, Dr Reddy’s Laboratories Limited, GSK plc, Merck KGaA, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Johnson Matthey, Gilead Sciences Inc., Allergan Plc, Cambrex Corporation, Siegfried Holding AG, BASF SE, Sanofi SA, Albany Molecular Research Inc., AstraZeneca Plc, and Hoffmann-La Roche Limited.

North America was the largest region in the small molecule active pharmaceutical ingredient market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the "small molecule active pharmaceutical ingredient market report" are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the small molecule active pharmaceutical ingredient market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The small molecule active pharmaceutical ingredient market consists of sales of standard API, HPAPI (high potency active pharmaceutical ingredients), branded synthetic API, generic synthetic API, and semi-synthetic API. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global small molecule active pharmaceutical ingredient market is segmented -

1) By Type: Synthetic, Chemical, or Biological

2) By Therapeutic Type: Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, Dermatology, Urology

3) By Manufacturing Method: In-House, Contract

4) By Application: Clinical, Commercial

    Table Of Contents

    1. Executive Summary

    2. Small Molecule Active Pharmaceutical Ingredient Market Characteristics

    3. Small Molecule Active Pharmaceutical Ingredient Market Trends And Strategies

    4. Small Molecule Active Pharmaceutical Ingredient Market - Macro Economic Scenario

    4.1. COVID-19 Impact On Small Molecule Active Pharmaceutical Ingredient Market

    4.2. Ukraine-Russia War Impact On Small Molecule Active Pharmaceutical Ingredient Market

    4.3. Impact Of High Inflation On Small Molecule Active Pharmaceutical Ingredient Market

    5. Small Molecule Active Pharmaceutical Ingredient Market Size And Growth

    5.1. Global Small Molecule Active Pharmaceutical Ingredient Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Small Molecule Active Pharmaceutical Ingredient Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Small Molecule Active Pharmaceutical Ingredient Market Segmentation

    6.1. Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Synthetic

    Chemical

    Biological

    6.2. Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Therapeutic Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Autoimmune Diseases

    Oncology

    Metabolic Diseases

    Ophthalmology

    Cardiovascular Diseases

    Infectious Diseases

    Neurology

    Respiratory Disorders

    Dermatology

    Urology

    6.3. Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Manufacturing Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    In-House

    Contract

    6.4. Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Clinical

    Commercial

    7. Small Molecule Active Pharmaceutical Ingredient Market Regional And Country Analysis

    7.1. Global Small Molecule Active Pharmaceutical Ingredient Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Small Molecule Active Pharmaceutical Ingredient Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market  

    8.1. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8.3. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Small Molecule Active Pharmaceutical Ingredient Market  

    9.1. China Small Molecule Active Pharmaceutical Ingredient Market Overview  

    9.2. China Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    9.3. China Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Small Molecule Active Pharmaceutical Ingredient Market  

    10.1. India Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    10.2. India Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Small Molecule Active Pharmaceutical Ingredient Market  

    11.1. Japan Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11.2. Japan Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Small Molecule Active Pharmaceutical Ingredient Market  

    12.1. Australia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12.2. Australia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Small Molecule Active Pharmaceutical Ingredient Market  

    13.1. Indonesia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13.2. Indonesia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Small Molecule Active Pharmaceutical Ingredient Market  

    14.1. South Korea Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14.2. South Korea Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Small Molecule Active Pharmaceutical Ingredient Market  

    15.1. Western Europe Small Molecule Active Pharmaceutical Ingredient Market Overview

    15.2. Western Europe Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15.3. Western Europe Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Small Molecule Active Pharmaceutical Ingredient Market  

    16.1. UK Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16.2. UK Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Small Molecule Active Pharmaceutical Ingredient Market  

    17.1. Germany Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17.2. Germany Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Small Molecule Active Pharmaceutical Ingredient Market  

    18.4. France Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18.5. France Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Small Molecule Active Pharmaceutical Ingredient Market  

    19.1. Eastern Europe Small Molecule Active Pharmaceutical Ingredient Market Overview

    19.2. Eastern Europe Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19.3. Eastern Europe Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Small Molecule Active Pharmaceutical Ingredient Market  

    20.1. Russia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20.2. Russia Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Small Molecule Active Pharmaceutical Ingredient Market  

    21.1. North America Small Molecule Active Pharmaceutical Ingredient Market Overview

    21.2. North America Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21.3. North America Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Small Molecule Active Pharmaceutical Ingredient Market  

    22.1. USA Small Molecule Active Pharmaceutical Ingredient Market Overview

    22.2. USA Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22.3. USA Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Small Molecule Active Pharmaceutical Ingredient Market  

    23.1. South America Small Molecule Active Pharmaceutical Ingredient Market Overview

    23.2. South America Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23.3. South America Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Small Molecule Active Pharmaceutical Ingredient Market  

    24.1. Brazil Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24.2. Brazil Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Small Molecule Active Pharmaceutical Ingredient Market  

    25.1. Middle East Small Molecule Active Pharmaceutical Ingredient Market Overview

    25.2. Middle East Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25.3. Middle East Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Small Molecule Active Pharmaceutical Ingredient Market  

    26.1. Africa Small Molecule Active Pharmaceutical Ingredient Market Overview

    26.2. Africa Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26.3. Africa Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Small Molecule Active Pharmaceutical Ingredient Market Competitive Landscape And Company Profiles

    27.1. Small Molecule Active Pharmaceutical Ingredient Market Competitive Landscape

    27.2. Small Molecule Active Pharmaceutical Ingredient Market Company Profiles

    27.2.1. Albemarle Corporation

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Aurobindo Pharma Limited

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Dr Reddy’s Laboratories Limited

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. GSK plc

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Merck KGaA

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Small Molecule Active Pharmaceutical Ingredient Market

    29. Small Molecule Active Pharmaceutical Ingredient Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Therapeutic Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Manufacturing Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Small Molecule Active Pharmaceutical Ingredient Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Global Small Molecule Active Pharmaceutical Ingredient Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: Asia-Pacific, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: Asia-Pacific, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: China, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: China, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: India, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: India, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Japan, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: Japan, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Australia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: Australia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Indonesia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Indonesia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: South Korea, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: South Korea, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: Western Europe, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Western Europe, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: UK, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: UK, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Germany, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 28: Germany, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 29: France, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 30: France, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 31: Eastern Europe, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 32: Eastern Europe, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 33: Russia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 34: Russia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 35: North America, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 36: North America, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 37: USA, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 38: USA, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 39: South America, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 40: South America, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 41: Brazil, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 42: Brazil, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 43: Middle East, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 44: Middle East, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 45: Africa, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 46: Africa, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 47: Albemarle Corporation Financial Performance
  • Table 48: Aurobindo Pharma Limited Financial Performance
  • Table 49: Dr Reddy’s Laboratories Limited Financial Performance
  • Table 50: GSK plc Financial Performance
  • Table 51: Merck KGaA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Therapeutic Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Manufacturing Method, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Small Molecule Active Pharmaceutical Ingredient Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Global Small Molecule Active Pharmaceutical Ingredient Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: Asia-Pacific, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: Asia-Pacific, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: China, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: China, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: India, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: India, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Japan, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: Japan, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Australia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: Australia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Indonesia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Indonesia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: South Korea, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: South Korea, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: Western Europe, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Western Europe, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: UK, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: UK, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Germany, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 28: Germany, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 29: France, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 30: France, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 31: Eastern Europe, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 32: Eastern Europe, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 33: Russia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 34: Russia, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 35: North America, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 36: North America, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 37: USA, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 38: USA, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 39: South America, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 40: South America, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 41: Brazil, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 42: Brazil, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 43: Middle East, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 44: Middle East, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 45: Africa, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 46: Africa, Small Molecule Active Pharmaceutical Ingredient Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 47: Albemarle Corporation Financial Performance
  • Figure 48: Aurobindo Pharma Limited Financial Performance
  • Figure 49: Dr Reddy’s Laboratories Limited Financial Performance
  • Figure 50: GSK plc Financial Performance
  • Figure 51: Merck KGaA Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report